NCT01978561View on ClinicalTrials.gov

Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up)

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

August 31, 2015

Study Completion Date

September 30, 2015

Conditions
Repeated IVF Failure
Interventions
BIOLOGICAL

Post dosing with NT100

OTHER

Post dosing with Placebo

Sponsors
All Listed Sponsors
lead

Nora Therapeutics, Inc.

INDUSTRY

NCT01978561 - Follow-Up Of Pregnancies Established During Study NT-03 (Thrive-IVF Follow-Up) | Biotech Hunter | Biotech Hunter